Liège, Belgium, 24 November 2017 – Regulated Information – Mithra Pharmaceuticals SA/NV (Euronext Brussels: MITRA) today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), that it received a notification of transparency from OGEO Fund OFP and from OGESIP Invest SA, an investment company controlled by OGEO Fund.